Patents
Patents for C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
02/2015
02/17/2015US8956999 Herbicides
02/03/2015US8945727 Organoselenium materials and their uses in organic light emitting devices
01/2015
01/13/2015US8933441 Organic electronic device
01/13/2015US8933102 Pyrrolidine derived β3 adrenergic receptor agonists
11/2014
11/11/2014US8884029 Dye for photoelectric conversion device and photoelectric conversion device
10/2014
10/28/2014US8871796 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
08/2014
08/13/2014CN103980269A 一种基于1,3,4-噻二唑的有机硒化合物及其制备方法和应用 A thiadiazole organic selenium compounds and their preparation method and application based
08/13/2014CN103980267A 一类新型黄嘌呤氧化酶抑制剂的化合物及其药物组合物 A new class of compounds and drugs xanthine oxidase inhibitor compositions
08/12/2014US8802675 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/06/2014EP2762472A2 Selenophene-fused aromatic compound and manufacturing method thereof
08/06/2014CN103965188A 含硒多奈哌齐类似物 Donepezil selenium analogues
07/2014
07/31/2014US20140213790 Selenophene-fused aromatic compound and manufacturing method thereof
07/30/2014CN103951664A 一种含有1,3,4-噻二唑和苯并异硒唑酮的衍生物及其制备方法和应用 Derivative and its preparation method and application containing 1,3,4-thiadiazole and benzisoselenazol ketone
07/23/2014CN102766111B 3,4-二芳基-1,2,5-硒二唑类衍生物及其用途 3,4-diaryl-1,2,5-oxadiazole derivatives of selenium and its use
07/23/2014CN102558168B 一种有机半导体材料及其制备方法和应用 An organic semiconductor material and its preparation method and application
07/15/2014US8779133 Compound, novel ligand, novel transition metal complex, and catalyst including novel transition metal complex
07/08/2014US8772500 TRPV3 modulators
07/08/2014US8772499 TRPV3 modulators
07/02/2014CN103906742A 硒吩稠合芳族化合物和其制备方法 Selenophene fused aromatic compounds and their preparation
07/02/2014CN102115610B 一类荧光染料、制备方法及其应用 A fluorescent dye, preparation method and its application
06/2014
06/18/2014CN102438449B Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
06/17/2014US8754226 Piperidinyl-substituted lactams as GPR119 modulators
06/11/2014CN103848798A 2-Arylselenazole compounds and medicinal composition thereof
06/05/2014WO2014082548A1 2-aryl selenazole compound and pharmaceutical composition thereof
05/2014
05/14/2014CN102695805B 用于测定样品中硫氧还蛋白还原酶活性的方法和试剂盒及应用 Methods and kits for use in the measurement sample and thioredoxin reductase activity
04/2014
04/23/2014CN101781283B Thioredoxin reductase inhibiter compounds and preparation method and application thereof
04/16/2014CN103732721A Luminescent solar concentrator comprising disubstituted benzoselenadiazole compounds
04/15/2014US8697721 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
04/09/2014CN101663283B Quinoxaline compounds and use thereof
04/08/2014US8691821 Oxazolidinones as modulators of mGluR5
03/2014
03/27/2014US20140088149 Bacterial thioredoxin reductase inhibitors and methods for use thereof
02/2014
02/04/2014US8642774 Compounds
02/04/2014US8642587 Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
01/2014
01/22/2014CN103524456A Selenazole acid compound and selenazole acid salt
01/08/2014EP2681255A2 Selenium-based monomers and conjugated polymers, methods of making, and use thereof
12/2013
12/24/2013US8614231 Immunosuppressor based on the blockage of TCR-Nck interaction
12/17/2013US8609686 Substituted azabicyclic compounds and the use thereof
12/10/2013US8604218 Cytoskeletal active rho kinase inhibitor compounds, composition and use
12/03/2013US8598206 Trypsin-like serine protease inhibitors, and their preparation and use
11/2013
11/12/2013US8580820 Tubulysin compounds with high cytotoxicity, pharmaceutical compositions thereof, and method of use thereof
10/2013
10/10/2013US20130266563 Substituted 4-(selenophen-2(or-3)-ylamino)pyrimidine compounds and methods of use thereof
10/01/2013US8546401 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
09/2013
09/26/2013US20130253006 2-selenophene-4-quinolones as anticancer agents
09/25/2013EP2640392A2 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
09/25/2013CN103319477A Organic selenium compounds based on 1,3,4-thiadiazole and 1,3,4-oxadiazole, as well as preparation method and application method thereof
09/24/2013US8541450 Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines
09/19/2013DE102013003605A1 Sekundäre Lochtransportschicht mit Tricarbazolverbindungen Secondary hole transport layer with Tricarbazolverbindungen
09/17/2013US8536182 Benzylpiperazine derivatives and their medical use
09/11/2013CN103288818A Anti-cancer drug based on benziso-selenazolone as well as preparation method and application thereof
08/2013
08/27/2013US8518560 Aromatic amine derivative and organic electroluminescent device using the same
08/06/2013US8501777 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission
08/06/2013US8501773 4-fluoro-piperidine T-type calcium channel antagonists
07/2013
07/31/2013EP2619200A2 Compounds that modulate intracellular calcium
07/16/2013US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders
07/10/2013EP2612669A2 Use of the fetal reprogramming of a ppar agonist
05/2013
05/23/2013WO2013048177A3 Selenophene-fused aromatic compound and manufacturing method thereof
05/21/2013US8445684 Nicotinic acetylcholine receptor ligands and the uses thereof
05/21/2013US8445683 Porphyrin compounds comprising one or more pyridone moieties
05/21/2013CA2396688C Glycosidase inhibitors and methods of synthesizing same
05/08/2013CN103094490A Organoselenium materials and their uses in organic light emitting devices
04/2013
04/24/2013CN101583280B Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents
04/16/2013US8420661 Arylethynyl derivatives
04/09/2013US8415378 Isoxazol-3(2H)-one analogs as therapeutic agents
03/2013
03/12/2013US8394835 Aromatic compounds and their use in medical applications
01/2013
01/15/2013US8354524 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids
01/03/2013US20130005963 Organic photoelectric conversion material and organic thin-film photoelectric conversion device
01/02/2013EP2540711A1 Selenalzole derivative having ligand which activates peroxisome proliferator activated receptor (ppar), preparing method thereof and usage of the chemical compounds
01/01/2013US8343913 Hsp90, buffering and drug resistance
12/2012
12/27/2012WO2012175536A1 Dyes, method of making them, and their use in dye-sensitized solar cells
11/2012
11/15/2012WO2012118818A3 Selenium-based monomers and conjugated polymers, methods of making, and use thereof
11/07/2012EP2520571A1 2-azatriphenylene materials for organic light emitting diodes
11/07/2012CN102766111A 3,4-diaryl-1,2,5-selenadiazole derivative and its application
10/2012
10/30/2012US8299258 Method of making piperidine derivatives
10/30/2012US8298766 Fluorescent dyes, methods of synthesis and applications thereof
09/2012
09/26/2012EP2501698A1 Fluorinated monomers, oligomers and polymers for use in organic electronic devices
09/13/2012US20120232237 Fluorinated Monomers, Oligomers and Polymers for Use in Organic Electronic Devices
09/07/2012WO2012118818A2 Selenium-based monomers and conjugated polymers, methods of making, and use thereof
09/04/2012US8258308 Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
07/2012
07/31/2012US8232298 Inhibitors of the interaction between MDM2 and P53
07/12/2012US20120178723 Heteroaryls and uses thereof
07/11/2012CN102575155A Novel organic electroluminescent compounds and organic electroluminescent device using the same
07/11/2012CN102558168A Organic semiconductor material and preparation method and application thereof
06/2012
06/27/2012EP2468747A1 2-Selenophene-4-quinolones as anticancer agents
06/14/2012WO2012040511A3 Compounds that modulate intracellular calcium
05/2012
05/30/2012CN102482222A 2-azatriphenylene materials for organic light emitting diodes
05/30/2012CN101555246B Halogen-containing asymmetry phthalocyanines compound, preparation method and application thereof
05/24/2012CA2818389A1 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
04/2012
04/24/2012US8163749 Six-membered heterocycles useful as serine protease inhibitors
04/17/2012US8157950 Aldimine and composition containing aldimine
03/2012
03/29/2012WO2012040511A2 Compounds that modulate intracellular calcium
03/27/2012US8143407 Process for production of heteroaryl-type boron compounds with iridium catalyst
03/27/2012US8143269 Inhibitors of store operated calcium release
03/21/2012EP2429997A1 2-azatriphenylene materials for organic light emitting diodes
03/21/2012EP1248779B1 Glycosidase ihhibitors and preparation thereof
01/2012
01/31/2012US8106206 Solid luminescent quinoline compounds
01/31/2012CA2670292C Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents
01/03/2012US8088802 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
11/2011
11/22/2011US8063072 Heterocyclic antiviral compounds
11/15/2011US8058291 Methods and compositions for the treatment of CNS-related conditions
10/2011
10/27/2011US20110262904 Fluorescent dyes,methods of synthesis and applications thereof
1 2 3 4 5